Cargando…
Model‐Based Approach to Predict Adherence to Protocol During Antiobesity Trials
Development of antiobesity drugs is continuously challenged by high dropout rates during clinical trials. The objective was to develop a population pharmacodynamic model that describes the temporal changes in body weight, considering disease progression, lifestyle intervention, and drug effects. Mar...
Autores principales: | Sharma, Vishnu D., Combes, François P., Vakilynejad, Majid, Lahu, Gezim, Lesko, Lawrence J., Trame, Mirjam N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811797/ https://www.ncbi.nlm.nih.gov/pubmed/28858397 http://dx.doi.org/10.1002/jcph.994 |
Ejemplares similares
-
A case study of a patient‐centered reverse translational systems‐based approach to understand adverse event profiles in drug development
por: Kim, Sarah, et al.
Publicado: (2022) -
Application of a patient‐centered reverse translational systems‐based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors
por: Kim, Sarah, et al.
Publicado: (2022) -
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis
por: Wei, Xiaohui, et al.
Publicado: (2017) -
Impact of Dose Delays and Alternative Dosing Regimens on Pertuzumab Pharmacokinetics
por: Liu, Stephanie N., et al.
Publicado: (2021) -
Population Pharmacokinetic Modeling and Simulations to Evaluate a Potential Dose Regimen of Testosterone Undecanoate in Hypogonadal Males
por: Pastuszak, Alexander W., et al.
Publicado: (2021)